Sunday 8 November 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB

Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024.

Revenue: +10.6%
EPS: −104.4%
Free cash flow: −69.3%
Total debt: +16.0%

Quarter to September 2026, against a year earlier

248.35 4.42 +1.81%

Follow BIIB

Alert me

Market cap: $36.1B
P/E: 105×
Fwd P/E: 46.4×
Dividend yield: —
F-score: 4/9
ROIC: 1.94%
Net debt / EBITDA: 0.8×
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
P/E ratio Full definition →	95.69	38.04	19.61	19.93	+8 more quarters Free account
P/S ratio Full definition →	3.24	3.18	2.72	2.61
P/FCF ratio Full definition →	19.70	12.56	11.24	12.77
P/Operating CF Full definition →	52.10	71.09	41.81	50.37
P/B ratio Full definition →	1.76	1.69	1.45	1.41
Price to Tangible BV Full definition →	0.00	0.00	8.68	9.97
EV/Sales Full definition →	3.82	3.78	2.92	2.86
EV/EBITDA Full definition →	17.20	14.71	9.57	9.62
EV/Operating CF Full definition →	17.52	13.17	11.19	12.82
EV/FCF Full definition →	23.24	14.93	12.07	13.99
Quick Ratio Full definition →	0.82	0.81	1.88	1.54
Current Ratio Full definition →	1.95	1.87	3.06	2.68
Net Debt/EBITDA Full definition →	10.57	10.18	2.83	5.84
Debt/Assets Full definition →	22.75%	22.72%	21.33%	21.35%
Debt/Equity Full definition →	0.39	0.39	0.34	0.34
Asset Turnover Full definition →	0.34	0.33	0.35	0.34
Operating CF/Net income Full definition →	(31.11)	4.60	2.02	(10.47)
Capex/Depreciation Full definition →	(0.61)	(0.40)	(0.16)	(0.19)
Research and Development Expense of Revenue Full definition →	20.47%	19.36%	21.75%	22.35%
Selling, General and Administrative Expense of Revenue Full definition →	26.82%	25.94%	24.51%	29.94%
Intangible Assets out of Total Assets Full definition →	0.64	0.64	0.53	0.53
Share Based Compensation of Revenue Full definition →	2.91%	2.83%	3.39%	2.61%
Graham Net Nets Full definition →	(0.17)	(0.19)	(0.06)	(0.09)
Graham Number Full definition →	82.46	127.71	163.27	157.35
Earnings Yield Full definition →	1.05%	2.63%	5.10%	5.02%
Free Cash Flow Yield Full definition →	5.08%	7.96%	8.90%	7.83%
Revenue per Share Full definition →	18.97	18.52	16.83	15.56
Operating CF per Share Full definition →	4.34	3.04	4.39	3.49
Capex per Share Full definition →	(1.80)	(1.19)	(0.35)	(0.41)
Free Cash Flow per Share Full definition →	2.54	1.85	4.04	3.08
Cash per Share Full definition →	8.82	8.70	29.09	26.05
Shareholders Equity per Share Full definition →	128.03	127.61	126.71	124.62
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	128.03	127.61	126.71	124.62
Free Cash Flow Full definition →	375.40	273.00	594.30	451.70
Working Capital Full definition →	3,686.00	3,388.60	6,191.50	5,624.70
Capital Expenditures Full definition →	(265.40)	(175.90)	(51.20)	(60.20)
Net Current Asset Value Full definition →	(5,547.60)	(5,932.90)	(1,641.00)	(2,208.60)
EV/EBIT Full definition →	50.80	30.63	15.42	15.17
Capex to Sales Full definition →	0.09	0.06	0.02	0.03
Price to Operating Income Full definition →	43.07	25.78	14.36	13.85
Other line items
Average Receivables Full definition →	1,629.35	1,754.90	1,682.85	1,373.60
Average Payables Full definition →	421.70	406.15	375.00	428.10
Average Inventory Full definition →	2,216.90	2,329.30	2,111.45	2,314.30
Average Assets Full definition →	30,630.80	30,208.40	28,758.10	28,744.40
Average Common Equity Full definition →	18,564.80	18,241.00	17,815.20	17,486.40

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly